Idose Tr (travoprost) PDUFA Date (Glaukos)
FDA PDUFA decision date for Idose Tr (travoprost) is January 27, 2026. Developed by Glaukos. Indication: Prostaglandin Analog [EPC]. Current status: Approved.
Indication
Prostaglandin Analog [EPC]
Regulatory details
- Company: Glaukos
- Application type: sNDA
- Review type: Standard
- PDUFA date: 2026-01-27
- Outcome: Approved